Cascadian Therapeutics Inc (USA) news

   Watch this stock
Showing stories 1 - 10 of about 80   

Articles published

CASC 1.14 0.00 (0.00%)
price chart
Company Update (NASDAQ:CASC): Cascadian Therapeutics Inc (USA) Announces ...
casc Cascadian Therapeutics Inc (USA) (NASDAQ:CASC) announced that it intends to offer and sell shares of its common stock in an underwritten public offering.
Cascadian Therapeutics Prices $41.8 Million Concurrent Offerings of Common ...  Investing News Network (press release) (registration) (blog)
Stock Update (NASDAQ:CASC): Cascadian Therapeutics Inc (USA) Receives ONT-380 ...
Cascadian Therapeutics (NASDAQ:CASC), a clinical-stage biopharmaceutical company, today announced that the ONT-380 program in advanced HER2+ metastatic breast cancer has received Fast Track designation from the U.S.
Cascadian boosted by FDA fast track for cancer drug  Proactive Investors USA & Canada
Cascadian's lead product candidate Fast Track'd for subtype of ...  Seeking Alpha
Biotech Beat: Analysts Weigh In On EXACT Sciences Corporation (EXAS ...
Exact shares rallied yesterday on an apparent leaked JAMA article unveiling that USPSTF highly recommends colon cancer screening from age 50 to 75, but will no longer rank tests; instead, it is providing a list of acceptable ones that includes FITDNA ...
Oncothyreon (ONTY) Changes Name to Cascadian Therapeutics; Will Begin Trading ...
Oncothyreon Inc. (Nasdaq: ONTY) (Nasdaq: CASC) announced that the Company is changing its name to Cascadian Therapeutics, Inc. and will trade on the NASDAQ Global Select Market under the new ticker symbol “CASC,” effective at market open on ...
Oncothyreon Renames Itself Cascadian Therapeutics (NASDAQ:ONTY)  Sonoran Weekly Review
Oncothyreon Presents Phase 1b Results of ONT-380 in Combination with T-DM1 ...  GlobeNewswire (press release)
Stocks Inside Traders Spotlight: Cascadian Therapeutics Inc (USA (NASDAQ:CASC ...
Cascadian Therapeutics Inc (USA (NASDAQ:CASC) went higher by +0.73% to close at $ 0.95. The company exchanged total volume of 676.67 thousand shares throughout course of last trade however it holds an average trading capacity of 1.13 million ...
Friday Stock's Trend: Cascadian Therapeutics Inc (USA) (NASDAQ:CASC), SPX ...
Cascadian Therapeutics Inc (USA) (NASDAQ:CASC) went lower by -3.4109% to close at $ 0.9175. The company exchanged total volume of 9.86 million shares throughout course of last trade however it holds an average trading capacity of 1.11 million shares ...
Cascadian Therapeutics Says New Data Support Advancement of ONT-380 Study ...
Cascadian Therapeutics Inc (USA) (NASDAQ:CASC) has declined 65.00% since November 5, 2015 and is downtrending. It has underperformed by 64.01% the S&P500.
Cascadian Therapeutics Inc. (CASC): Billionaire Seth Klarman's Baupost Group ...
Billionaire Seth Klarman's Baupost Group recently reported a new stake in Cascadian Therapeutics Inc. (NASDAQ:CASC), in a 13G filing with the SEC.
Seth Klarman Buys 25 Million Shares of Cascadian Therapeutics  Nasdaq
Seth Klarman Buys —5 Million Shares of Cascadian Therapeutics  GuruFocus.com
Stocks Under Review - Simon Property Group, (NYSE:SPG), Cascadian Therapeutics ...
Shares of Cascadian Therapeutics Inc (USA) (NASDAQ:CASC) climbed 3.48% to $1.19. Checking in on YTD performance, the stock is -46.40%.
BRIEF-Oncothyreon says company is changing its name to Cascadian Therapeutics
June 8 (Reuters) -. * Oncothyreon Inc says company is changing its name to cascadian therapeutics, inc. * Oncothyreon Inc says will trade on nasdaq global select market under new ticker symbol "CASC," effective at market open on June 9, 2016 Source ...